Article info
PDFOriginal article
The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis
- Correspondence to Dr Judith Cave, Department of Oncology, University Hospital NHS Foundation Trust, Tremona Road, Southampton, Hampshire SO166YD, UK; judith.cave{at}uhs.nhs.uk
Citation
The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis
Publication history
- Received August 17, 2015
- Revised November 6, 2015
- Accepted November 15, 2015
- First published December 17, 2015.
Online issue publication
June 14, 2020
Article Versions
- Previous version (20 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/